Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

GSK Introduces a New Anti-BCMA (B-cell maturation antigen) Therapy, BLENREP

GlaxoSmithKline plc, introduces BLENREP a first-in-class anti-BCMA (B-cell maturation antigen) therapy for the treatment of adult patients with relapsed or refractory multiple myeloma who have undergone at least four prior therapies including an anti-CD38 monoclonal antibody...

AXS-12 Novel Therapy Discovered for the Treatment of Narcolepsy

Axsome Therapeutics, Inc discovered AXS-12 novel therapy for the treatment of cataplexy in patients with narcolepsy. AXS-12 is an oral, highly selective and potent norepinephrine reuptake inhibitor. AXS-12, developed for cataplexy highlights its potential and provides meaningful benefit and substantial improvement for patients over currently available treatment...

Rozlytrek® (entrectinib), The First Tumour-Agnostic Therapy Discovered

Rozlytrek® (entrectinib), the first tumour-agnostic therapy discovered for the treatment of patients with NTRK fusion-positive, locally advanced or metastatic solid tumours in adult and paediatric patients who have either progressed following prior therapies or who have no acceptable standard therapies....

AstraZeneca Introduces A Breakthrough Therapy-Tagrisso

AstraZeneca introduced Tagrisso (osimertinib), a breakthrough therapy for the adjuvant treatment of patients with early-stage (IB, II and IIIA) Epidermal Growth Factor Receptor-mutated (EGFRm) Non-Small Cell Lung Cancer (NSCLC)....

Merck Discovers Breakthrough Therapy HIF-2α Inhibitor MK-6482

Hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482, a novel breakthrough therapy discovered by Merck for the treatment of patients with von Hippel-Lindau (VHL) disease-associated Renal Cell Carcinoma (RCC)....

Pevonedistat Novel Therapy Developed for the Treatment of Patients with HR-MDS

Takeda Pharmaceutical has developed Pevonedistat, a NEDD8-activating enzyme (NAE) inhibitor,a novel treatment for Higher-Risk Myelodysplastic Syndromes (HR-MDS) patients....

TECARTUS™ Discovered for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Kite discovered Tecartus™ (brexucabtageneautoleucel, formerly KTE-X19), a novel Chimeric Antigen Receptor (CAR) T for the treatment of adult patients with relapsed or refractory Mantle Cell Lymphoma (MCL)....

CTP-543 Novel Therapy Introduced for the Treatment of Alopecia Areata

Concert Pharmaceuticals, Inc introduces CTP-543, Oral Janus kinase inhibitor for the treatment of moderate-to-severe alopecia areata in adult patients....

Talaris Therapeutics Develops Novel Cell Therapy FCR001 for the Treatment of Scleroderma

Novel cell therapy FCR001, was developed by Talaris for the treatment of patients with diffuse systemic sclerosis (SSc), a severe form of the rare autoimmune disease scleroderma....

A Breakthrough Therapy Developed for Investigational Prenatal Treatment ER-004 a Rare Genetic Condition

ER-004, a breakthrough therapy for the prenatal treatment of XLHED, a life-threatening rare genetic condition was developed by EspeRare....

Gvoke HypoPen™ First Autoinjector Discovered for Severe Hypoglycemia

Xeris Pharmaceuticals, Inc discovered novel Gvoke HypoPen™ (glucagon injection),which is used for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years and above....

GIMOTI™, Novel Nasal Spray Developed for Treatment of Gastroparesisin Adults

GIMOTI™ (metoclopramide), novel nasal spray developed by Evoke Pharma, Inc specifically for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis....

Breakthrough Therapy, Crysvita Discovered For Treatment of Tumor-Induced Osteomalacia (TIO)

Crysvita (burosumab-twza) injection the first therapy discovered for the treatment of patients with rare disease, tumor-induced osteomalacia (TIO) corresponding to the age two and older....

Eli Lilly and Company Launched New Rapid Acting Insulin Lyumjev™

Lyumjev™, a new and innovative rapid acting insulin ranging from 100 units/mL and 200 units/mL was launched by Eli Lilly and Company to enhance glycemic control in diabetic patients of type 1 & 2....

A Novel Oral Therapy Discovered to Treat Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Insmed discovered Brensocatib for the treatment of adult patients with Non-cystic Fibrosis Bronchiectasis (NCFBE) for reducing exacerbations. Brensocatib is a novel oral, reversible inhibitor of Dipeptidyl Peptidase 1 (DPP1) for the treatment of bronchiectasis and other inflammatory diseases....

Retevmo™, The First Therapy Developed for Patients with Advanced RET-Driven Lung and Thyroid Cancers

Eli Lilly and Company discovered Retevmo™ (selpercatinib, 40 mg & 80 mg capsules) to treat patients with different types of cancers such as non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer....

SUNOVION Launches KYNMOBI™ for the Treatment of Parkinson's Disease Off Episodes

Sunovion Pharmaceuticals Inc launched a novel drug KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease....

Archer, Inc Launches Next-Generation Sequencing (NGS) Device to Identify NTRK Gene Fusions in Cancer

ArcherDX, Inc has discovered a new next-generation sequencing (NGS) device to detect Neurotrophic Receptor Tyrosine Kinase (NTRK) gene fusions that leads to the formation and growth of cancer....

Deciphera Pharmaceuticals’ Develops QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumors in Adults

Deciphera Pharmaceuticals developed QINLOCK™ (ripretinib) 50mg capsules to treat adult patients with advanced gastrointestinal stromal tumour (GIST) who underwent prior treatment with three or more kinase inhibitors, including imatinib....

UoFL Researchers Discovered Novel Technology that Shows Promise Fighting Coronavirus

The researchers at the University of Louisville have discovered a technology for their research in fighting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)responsible for the COVID-19 pandemic....